MedPath

Effects of Repetitive peripheral magnetic stimulation rPMS on Ankle downward movement spasticity Ankle upward movers range Strength and ability to move in stroke patients A Pilot Study

Not Applicable
Conditions
Health Condition 1: I67- Other cerebrovascular diseasesHealth Condition 2: G811- Spastic hemiplegia
Registration Number
CTRI/2022/12/048273
Lead Sponsor
Ragendhu S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Stroke patients

Age group 18 â?? 80 years

Both genders

Spasticity level â?? Grade 2 & 3 according to modified tardieu scale

Able to walk at least 10 metres with or without assistance.

Exclusion Criteria

History of multiple strokes

Neurological conditions other than stroke causing spasticity

Orthopaedic conditions or deformities affecting functional mobility

Botulinum toxin injection for plantar flexor within last 6 months

MMSE score less than 24

Patients with metal implants near the rPMS stimulation site.

Patients with infection such as (cellulitis) near the rPMS stimulation site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modified Tardieu ScaleTimepoint: Pre treatment <br/ ><br>Post treatment assessment will be done at the end of 3 weeks <br/ ><br>Follow up will be taken at 1 month and 3 month
Secondary Outcome Measures
NameTimeMethod
Timed up and Go test <br/ ><br>Ankle lunge test <br/ ><br>Digital dynamometerTimepoint: Pre treatment <br/ ><br>Post treatment assessment will be done at the end of 3 weeks <br/ ><br>Follow up measurements will be taken at 1 month 3 and 6 month
© Copyright 2025. All Rights Reserved by MedPath